JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds
Signaling Pathways

Signaling Pathways

B1036 MLN4924
35 Citation

Target: NAE|Ubiquitin-activating Enzyme E1|SUMOylation

Summary: NAE inhibitor

≥22.18 mg/mL
B2163 SB408124

Summary: OX(1)receptor antagonist
B1935 Dronedarone HCl

Summary: Antiarrhythmic drugs

≥28.25 mg/mL
B1444 Etodolac

Summary: COX-2 inhibitor

insoluble in H2O; ≥14.37 mg/mL
B1908 Chenodeoxycholic Acid

Summary: nuclear receptors(FXR) activator

insoluble in H2O; ≥13.05 mg/mL
B1018 (S)-(+)-Ibuprofen

Summary: COX inhibitor
B1043 (R)-(-)-Ibuprofen

Summary: Inhibitor of Cox-1 and Cox-2

insoluble in H2O; ≥12.8 mg/mL
B1307 SJB3-019A

Target: USP

Summary: Usp1 inhibitor

insoluble in H2O; insoluble in EtOH; ≥10.85 mg/mL
B2224 Etravirine (TMC125)

Target: Reverse Transcriptases

Summary: Reverse transcriptase inhibitor

insoluble in EtOH; insoluble in H2O; ≥19.35 mg/mL
B1620 Tolterodine tartrate

Target: AChR

Summary: Competitive muscarinic receptor antagonist

≥23.78 mg/mL